About: Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1996 (uk) article scientifique publié en 1996 (fr) im November 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 1996 (ast) scientific article published on 01 November 1996 (en)
publication date	wds:Q71724578-E7E8B7B8-8932-48B8-9D3D-4B3EBE3AC31A
publication date	1996-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71724578-80EBDA5A-D776-4441-BE09-78DF70AC57BF
language of work or name	English
cites work	wds:Q71724578-0D1BA8C7-B720-4EC5-B1A0-5EBE6CAE4FED wds:Q71724578-0D3C8F6A-B3C6-4D86-A76E-0CA5E43762EC wds:Q71724578-12228121-37D3-4DD1-9471-81B9685845C2 wds:Q71724578-1455B1C2-0EC5-4875-BF73-03793CF412D4 wds:Q71724578-2366064E-DDDF-4A25-98AC-62516B7CEB30 wds:Q71724578-23E7A55E-AF18-462C-B79B-AECD9B45D27A wds:Q71724578-26A295A5-52F3-482C-86C6-2B4FC23C60A9 wds:Q71724578-2C4852D2-12DC-493E-9A96-273876FD50F4 wds:Q71724578-322E3BD2-4EE2-4913-B336-CDF1E61E3D98 wds:Q71724578-6FD31F5D-5471-4BAE-AC19-DBD3CC1D90B6 wds:Q71724578-8F1B59B9-B6B7-40EE-B281-E5D0E98191E2 wds:Q71724578-A6B8B6AD-151C-498D-924C-8784489C4A1B wds:Q71724578-B19B07D6-5C79-42AB-89B8-4E1F2A50D547 wds:Q71724578-BCB1CAB5-075E-444D-941B-B230B5D11C3B wds:Q71724578-DDE5EBF9-21CF-4B9B-BAF2-6D9FCED4773A wds:Q71724578-E3C7902C-882C-4FE8-B79A-0715EC8ED0F5 wds:Q71724578-ED2D1305-11B5-46F6-B715-924AE60850EB wds:Q71724578-F28C3AC4-616D-4F97-AEFB-7A2BA0627B62 wds:Q71724578-F670B308-7A41-4BDD-8FFA-022E45DB02FF wds:Q71724578-FDA2403B-CC41-4613-83AB-B854994B5E73
cites work	The placebo effect in heart failure Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical res Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial) Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment
author name string	wds:Q71724578-C2830374-8757-4F9F-AA8F-C8F48C88F4B2
author name string	Packer M
rdfs:label	Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? (en) Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? (nl)
skos:prefLabel	Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? (en) Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? (nl)
name	Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? (en) Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? (nl)
title	wds:Q71724578-7B0A895B-68C0-48BA-821A-0893116A48EB
title	Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? (en)
page(s)	wds:Q71724578-4E11482A-100D-47A5-AAEA-12FC99368647
page(s)	1323-1327
instance of	wds:Q71724578-0BA3DED1-C20A-44B6-A9A5-DD8FE2E1CB60 wds:Q71724578-7a160e67-caa6-4474-8ffa-af9b0e1290b9 wds:Q71724578-f276ee39-40da-463b-87f2-00720989996a
instance of	editorial review article scholarly article
main subject	wds:Q71724578-D5D89706-07B1-42E7-9340-E64B373EBB88
main subject	heart failure
PubMed ID	wds:Q71724578-A6ABCAE4-4405-40E7-A660-4E70EB3E8671
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8890833
PubMed ID	8890833
published in	wds:Q71724578-2B2CF2F1-0378-4918-8ED8-1270A8CE3410
published in	Journal of the American College of Cardiology
issue	wds:Q71724578-BAA1A4C0-0C84-4EB1-B50C-CF7FAC970A7C
volume	wds:Q71724578-FEE95698-532E-4777-A720-2F1D6DBDDA3C
issue	5
volume	28
DOI	wds:Q71724578-4D254214-8DEB-42BB-84FA-3E626A776D8F
DOI	http://dx.doi.org/10.1016/S0735-1097(96)00301-4
DOI	10.1016/S0735-1097(96)00301-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71724578
is cites work of	First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization Current clinical pathophysiologic considerations in essential hypertension Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure The economic burden of heart failure Lisinopril: a review of its use in congestive heart failure High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril. Management of acute myocardial infarction in general medical wards in Sri Lanka Current medical therapy for advanced heart failure Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Convert Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines Improved outcomes from a comprehensive management system for heart failure Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? Is the optimal dose of angiotensin-converting enzyme inhibitors in patients with congestive heart failure definitely established? Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software